Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access
NCT: NCT05846581 · RECRUITING
Brief Summary
The goal of this observational study is to evaluate safety and performance of GORE® ACUSEAL Vascular Graft for the treatment of CKD in patients with ESRD in hemodialysis. The main questions it aims to answer are: * Safety: Freedom from device-related infection adverse events at 24 months from device implant * Performance: Secondary patency at 24 months from device implant. Participants, after informed consent is obtained, will be implanted with GORE® ACUSEAL Vascular Graft and followed for 24 months in standard of care, to evaluate safety and performance of the device.
Frequently Asked Questions
What is Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access?
Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access is a clinical trial registered under NCT05846581. Current status: RECRUITING.
What is the status of NCT05846581?
The current status of NCT05846581 (Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access) is: RECRUITING.
When did Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access start?
Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access started on 2024-01-12.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.